# A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Sinotau Pharmaceutical Group · Condition: Advanced Neuroendocrine Neoplasm

- Company: Sinotau Pharmaceutical Group
- Sector: Advanced Neuroendocrine Neoplasm
- Primary source: https://clinicaltrials.gov/study/NCT06398444

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.